English

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION MEDICATION NCT00291876

1 forms  
Study administration
Description

Study administration

Center
Description

Center

Data type

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Date of Visit
Description

Date of Visit

Data type

date

Alias
UMLS CUI [1]
C1320303
Subject Number
Description

Subject Identifier

Data type

integer

Alias
UMLS CUI [1]
C2348585
MEDICATION
Description

MEDICATION

Have any of the above mentioned medications/treatments been administered during the period starting 30 days prior to the vaccine dose and ending one month [minimum 30 days] after it?
Description

pharmaceutical preparations

Data type

integer

Alias
UMLS CUI [1]
C0013227
MEDICATION
Description

MEDICATION

undefined item
Description

undefined item

Data type

text

Back to the top of the page

Similar models

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION MEDICATION NCT00291876

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Study administration
Center
Item
Center
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Subject Identifier
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
MEDICATION
Item
Have any of the above mentioned medications/treatments been administered during the period starting 30 days prior to the vaccine dose and ending one month [minimum 30 days] after it?
integer
C0013227 (UMLS CUI [1])
pharmaceutical preparations
Code List
Have any of the above mentioned medications/treatments been administered during the period starting 30 days prior to the vaccine dose and ending one month [minimum 30 days] after it?
CL Item
No (1)
CL Item
Yes, please complete the following table. (2)
Item Group
MEDICATION
undefined item
Item
text
Back to the top of the page